Preoperative serum cystatin-C as a potential biomarker for prognosis of renal cell carcinoma

• Shengjie Guo ,

  Contributed equally to this work with: Shengjie Guo, Yunfei Xue, Qiuming He

  Affiliation Department of Urology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

  ⨯
• Yunfei Xue ,

  Contributed equally to this work with: Shengjie Guo, Yunfei Xue, Qiuming He

  Affiliation Medicine school of Sun Yat-Sen University, Guangzhou, China

  ⨯
• Qiuming He ,

  Contributed equally to this work with: Shengjie Guo, Yunfei Xue, Qiuming He

  Affiliation Department of Urology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

  ⨯
• Xiaobo He,

  Affiliation Department of Medical Oncology, the Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, China

  ⨯
• Kunbin Guo,

  Affiliation Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, China

  ⨯
• Pei Dong,

  Affiliation Department of Urology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

  ⨯
• Kai Yao,

  Affiliation Department of Urology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

  ⨯
• Guangwei Yang,

  Affiliation Medicine school of Sun Yat-Sen University, Guangzhou, China

  ⨯
• Dong Chen,

  Affiliation Department of Urology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

  ⨯
• Zaishang Li,

  Affiliation Department of Urology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

  ⨯
• Xiangdong Li,

  Affiliation Department of Urology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

  ⨯
• Zike Qin,

  Affiliation Department of Urology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

  ⨯
• Zhuowei Liu,

  Affiliation Department of Urology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

  ⨯
• Wenjie Cheng,

  Affiliation Department of Urology, the Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, China

  ⨯
• Chao Guo,

  Affiliation The Jiangcheng Branch of Yangjiang People’s Hospital, Yangjiang, Guangdong, China

  ⨯
• Meng Zhang,

  Affiliation Medicine school of Sun Yat-Sen University, Guangzhou, China

  ⨯
• Hui Han ,

  * E-mail: hanhui@sysucc.org.cn (HH); zhoufj@sysucc.org.cn (FZ)

  Affiliation Department of Urology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

  ⨯
•  [ ... ],
• Fangjian Zhou

  * E-mail: hanhui@sysucc.org.cn (HH); zhoufj@sysucc.org.cn (FZ)

  Affiliation Department of Urology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

  ⨯
• [ view all ]
• [ view less ]